Group 1: Earnings Performance - Aemetis reported a quarterly loss of $0.41 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.35, representing an earnings surprise of -17.14% [1] - The company posted revenues of $52.24 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 35.62%, compared to year-ago revenues of $66.56 million [2] - Over the last four quarters, Aemetis has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Group 2: Stock Performance and Outlook - Aemetis shares have lost about 4.5% since the beginning of the year, while the S&P 500 has gained 7.9% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is -$0.26 on revenues of $104.19 million, and -$1.34 on revenues of $332.8 million for the current fiscal year [7] Group 3: Industry Context - The Biofuels industry, to which Aemetis belongs, is currently in the top 41% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Aemetis' stock performance [5][6]